Cliff Asness’s Sanara MedTech SMTI Stock Holding History

Cliff Asness’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65M	Buy	112,207 +72,269	+181%	+$1.49M	﹤0.01%	2432
2026 Q1	$686K	Buy	+39,938	New	+$822K	﹤0.01%	2971

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Cliff Asness's SMTI Position: Q2 2026 in Review

Cliff Asness increased its Sanara MedTech (SMTI) stake by 181% in Q2 2026, buying an estimated $1.49M and bringing the position to 112,207 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2432.

Cliff Asness first reported a position in SMTI in Q1 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Cliff Asness held 112,207 shares of Sanara MedTech worth $2.65M as of Q2 2026.
Cliff Asness bought 72,269 Sanara MedTech shares in Q2 2026, an estimated $1.49M.
Sanara MedTech made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2432 holding.
Cliff Asness first reported a position in Sanara MedTech in Q1 2026 and has held it in 2 quarters since.
74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.